Pieris Pharmaceuticals Inc

General ticker "PIRS" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $21.4M

Pieris Pharmaceuticals Inc follows the US Stock Market performance with the rate: 13.8%.

Estimated limits based on current volatility of 4.2%: low 14.88$, high 16.19$

Factors to consider:

  • Earnings for 9 months up through Q3 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2023-12-31 to 2025-12-30

  • 2023-12-31 to 2024-12-30 estimated range: [7.55$, 23.35$]
  • 2024-12-30 to 2025-12-30 estimated range: [9.18$, 24.44$]

Financial Metrics affecting the PIRS estimates:

  • Negative: Non-GAAP EPS, $ of -23.20 <= 0.10
  • Negative: Operating profit margin, % of -41.01 <= 1.03
  • Negative: negative Net income
  • Negative: Operating cash flow per share per price, % of -76.98 <= 2.35
  • Positive: Interest expense per share, $ of 0 <= 0
  • Negative: Industry operating cash flow per share per price (median), % of -23.87 <= 3.85

Similar symbols

Short-term PIRS quotes

Long-term PIRS plot with estimates

Financial data

YTD 2021-12-31 2022-12-31 2023-12-31
Operating Revenue $31.42MM $25.90MM $42.81MM
Operating Expenses $83.25MM $69.38MM $72.57MM
Operating Income $-51.83MM $-43.47MM $-29.76MM
Non-Operating Income $6.09MM $10.20MM $5.21MM
R&D Expense $66.66MM $52.98MM $41.80MM
Income(Loss) $-45.74MM $-33.28MM $-24.54MM
Taxes $0.00MM $-2.02MM $0.00MM
Profit(Loss) $-45.74MM $-31.25MM $-24.54MM
Stockholders Equity $50.76MM $27.93MM $26.76MM
Assets $153.56MM $95.49MM $38.68MM
Operating Cash Flow $-7.66MM $-59.93MM $-53.82MM
Capital expenditure $0.95MM $1.04MM $0.17MM
Investing Cash Flow $-0.95MM $-21.24MM $12.00MM
Financing Cash Flow $59.13MM $7.21MM $19.80MM
Earnings Per Share* $-53.75 $-33.71 $-21.80

* EPS are Split Adjusted, recent splits may be reflected with a delay.